199 related articles for article (PubMed ID: 37133984)
1. Expanding Transition Metal-Mediated Bioorthogonal Decaging to Include C-C Bond Cleavage Reactions.
Dal Forno GM; Latocheski E; Beatriz Machado A; Becher J; Dunsmore L; St John AL; Oliveira BL; Navo CD; Jiménez-Osés G; Fior R; Domingos JB; Bernardes GJL
J Am Chem Soc; 2023 May; 145(19):10790-10799. PubMed ID: 37133984
[TBL] [Abstract][Full Text] [Related]
2. Controlled In-Cell Generation of Active Palladium(0) Species for Bioorthogonal Decaging.
Konč J; Sabatino V; Jiménez-Moreno E; Latocheski E; Pérez LR; Day J; Domingos JB; Bernardes GJL
Angew Chem Int Ed Engl; 2022 Feb; 61(8):e202113519. PubMed ID: 34739737
[TBL] [Abstract][Full Text] [Related]
3. A Carbon-Carbon Bond Cleavage-Based Prodrug Activation Strategy Applied to β-Lapachone for Cancer-Specific Targeting.
Gong Q; Li X; Li T; Wu X; Hu J; Yang F; Zhang X
Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202210001. PubMed ID: 35938884
[TBL] [Abstract][Full Text] [Related]
4. General Strategy for Integrated Bioorthogonal Prodrugs: Pt(II)-Triggered Depropargylation Enables Controllable Drug Activation
Sun T; Lv T; Wu J; Zhu M; Fei Y; Zhu J; Zhang Y; Huang Z
J Med Chem; 2020 Nov; 63(22):13899-13912. PubMed ID: 33141588
[TBL] [Abstract][Full Text] [Related]
5. Bioorthogonal Decaging Reactions for Targeted Drug Activation.
Davies S; Stenton BJ; Bernardes GJL
Chimia (Aarau); 2018 Nov; 72(11):771-776. PubMed ID: 30514419
[TBL] [Abstract][Full Text] [Related]
6. Development and bioorthogonal activation of palladium-labile prodrugs of gemcitabine.
Weiss JT; Dawson JC; Fraser C; Rybski W; Torres-Sánchez C; Bradley M; Patton EE; Carragher NO; Unciti-Broceta A
J Med Chem; 2014 Jun; 57(12):5395-404. PubMed ID: 24867590
[TBL] [Abstract][Full Text] [Related]
7. Rational Utilization of Black Phosphorus Nanosheets to Enhance Palladium-Mediated Bioorthogonal Catalytic Activity for Activation of Therapeutics.
Rong M; Liu J; Sun Z; Li T; Li Y; Jiang C; Lu L
Angew Chem Int Ed Engl; 2023 May; 62(19):e202216822. PubMed ID: 36917027
[TBL] [Abstract][Full Text] [Related]
8. Modular Nanoparticulate Prodrug Design Enables Efficient Treatment of Solid Tumors Using Bioorthogonal Activation.
Miller MA; Mikula H; Luthria G; Li R; Kronister S; Prytyskach M; Kohler RH; Mitchison T; Weissleder R
ACS Nano; 2018 Dec; 12(12):12814-12826. PubMed ID: 30550257
[TBL] [Abstract][Full Text] [Related]
9. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.
Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA
Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761
[TBL] [Abstract][Full Text] [Related]
10. A bioorthogonal nanosystem for imaging and in vivo tumor inhibition.
Li B; Liu P; Wu H; Xie X; Chen Z; Zeng F; Wu S
Biomaterials; 2017 Sep; 138():57-68. PubMed ID: 28554008
[TBL] [Abstract][Full Text] [Related]
11. Development of a self-immolative linker for tetrazine-triggered release of alcohols in cells.
Davies S; Oliveira BL; Bernardes GJL
Org Biomol Chem; 2019 Jun; 17(23):5725-5730. PubMed ID: 31135016
[TBL] [Abstract][Full Text] [Related]
12. Platinum-Triggered Bond-Cleavage of Pentynoyl Amide and
Oliveira BL; Stenton BJ; Unnikrishnan VB; de Almeida CR; Conde J; Negrão M; Schneider FSS; Cordeiro C; Ferreira MG; Caramori GF; Domingos JB; Fior R; Bernardes GJL
J Am Chem Soc; 2020 Jun; 142(24):10869-10880. PubMed ID: 32456416
[TBL] [Abstract][Full Text] [Related]
13. In-Cell Dual Drug Synthesis by Cancer-Targeting Palladium Catalysts.
Clavadetscher J; Indrigo E; Chankeshwara SV; Lilienkampf A; Bradley M
Angew Chem Int Ed Engl; 2017 Jun; 56(24):6864-6868. PubMed ID: 28485835
[TBL] [Abstract][Full Text] [Related]
14. Photo-Uncaging by C(sp
Kaye EG; Mirabi B; Lopez-Miranda IR; Dissanayake KC; Banerjee U; Austin M; Lautens M; Winter AH; Beharry AA
J Am Chem Soc; 2023 Jun; 145(23):12518-12531. PubMed ID: 37265114
[TBL] [Abstract][Full Text] [Related]
15. Transition Metal-mediated Uncaging Chemistry in Prodrug Design.
Shu HY; De Zhu R; Wu J; Liu XH; Shi JB
Curr Top Med Chem; 2021; 21(24):2205-2212. PubMed ID: 34170808
[TBL] [Abstract][Full Text] [Related]
16. A Bioorthogonal Decaging Chemistry of
Yan Z; Pan Y; Jiao G; Xu M; Fan D; Hu Z; Wu J; Chen T; Liu M; Bao X; Ke H; Ji X
J Am Chem Soc; 2023 Nov; 145(45):24698-24706. PubMed ID: 37933858
[TBL] [Abstract][Full Text] [Related]
17. Extracellular palladium-catalysed dealkylation of 5-fluoro-1-propargyl-uracil as a bioorthogonally activated prodrug approach.
Weiss JT; Dawson JC; Macleod KG; Rybski W; Fraser C; Torres-Sánchez C; Patton EE; Bradley M; Carragher NO; Unciti-Broceta A
Nat Commun; 2014; 5():3277. PubMed ID: 24522696
[TBL] [Abstract][Full Text] [Related]
18. C-F and C-H bond activation of fluorobenzenes and fluoropyridines at transition metal centers: how fluorine tips the scales.
Clot E; Eisenstein O; Jasim N; Macgregor SA; McGrady JE; Perutz RN
Acc Chem Res; 2011 May; 44(5):333-48. PubMed ID: 21410234
[TBL] [Abstract][Full Text] [Related]
19. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy.
Ma X; Huang X; Moore Z; Huang G; Kilgore JA; Wang Y; Hammer S; Williams NS; Boothman DA; Gao J
J Control Release; 2015 Feb; 200():201-11. PubMed ID: 25542645
[TBL] [Abstract][Full Text] [Related]
20. Bioorthogonal catalytic patch.
Chen Z; Li H; Bian Y; Wang Z; Chen G; Zhang X; Miao Y; Wen D; Wang J; Wan G; Zeng Y; Abdou P; Fang J; Li S; Sun CJ; Gu Z
Nat Nanotechnol; 2021 Aug; 16(8):933-941. PubMed ID: 33972760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
